Bacterial translocation inhibitor and method of inhibiting bacterial translocation
AssigneeCalpis Co., Ltd.
InventorsToshihiro Marubashi, Tomokazu Imabayashi, Kiyoshi Maruta
Life of this patent
Estimating the term…
Abstract
A bacterial translocation inhibitor containing live Bacillus subtilis cells as an active ingredient, and a method for inhibiting bacterial translocation comprising the step of orally administering the bacterial translocation inhibitor.
Claims7
1-3. (canceled)
A method for inhibiting a disease associated with bacterial translocation comprising the step of orally administering to a subject in need thereof a bacterial translocation inhibitor containing live Bacillus subtilis C-3102 (deposited at National Institute of Bioscience and Human-Technology with deposition number FERM BP-1096) cells as an active ingredient, in an effective amount for enhancement of intestinal barrier function.
A method for enhancing intestinal barrier function, comprising the step of orally administering to a subject in need thereof an effective amount of a bacterial translocation inhibitor containing live Bacillus subtilis C-3102 (deposited at National Institute of Bioscience and Human-Technology with deposition number FERM BP-1096) cells as an active ingredient, whereby a disease associated with bacterial translocation is inhibited.
Dependencies are inferred from the claim text.